Sirio Pharma Co., Ltd. (300791.SZ)
CNY 28.09
(-0.46%)
CNY 28.09
(-0.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 386.08 Million | 444.85 Million | 341.37 Million | 319.57 Million | 231.6 Million | 183.45 Million |
| Net Income | 240.28 Million | 212.28 Million | 231.83 Million | 257.36 Million | 142.52 Million | 203.22 Million |
| Depreciation & Amortization | 256.95 Million | 131.74 Million | 104.06 Million | 79.71 Million | 71.57 Million | 54.96 Million |
| Deferred income taxes | -13.33 Million | 12.85 Million | 14.77 Million | 18.04 Million | -4.46 Million | -3.03 Million |
| Stock-based compensation | 1.73 Million | -3.98 Million | 21.3 Million | 7.76 Million | - | - |
| Change in working capital | -191.28 Million | 23.5 Million | -28.73 Million | -23.63 Million | 3.71 Million | -103.4 Million |
| Other non-cash items | 80.12 Million | 77.32 Million | 34.21 Million | 6.12 Million | 13.78 Million | 28.67 Million |
| Investing Cash Flow | -1.15 Billion | 283.9 Million | -735.47 Million | -394.97 Million | -597.86 Million | -238.67 Million |
| Investments in PPE | -451.7 Million | -293.69 Million | -524.68 Million | -223.14 Million | -166.89 Million | -239.32 Million |
| Acquisitions | -707.54 Million | - | 454.37 Thousand | 19.39 Thousand | 186.72 Thousand | 29.98 Thousand |
| Investment purchases | -682.56 Million | -2.15 Billion | -1.56 Billion | -620 Million | -446.1 Million | - |
| Sales/Maturities of investments | 581.61 Million | 2.86 Billion | 1.34 Billion | 446.94 Million | 16.14 Million | 617.52 Thousand |
| Other Investing Activities | 102.33 Million | -126.36 Million | 1.93 | 1.2 Million | -1.19 Million | 29.99 Thousand |
| Financing Cash Flow | -91.14 Million | -77.89 Million | 906.11 Million | -92.91 Million | 680.87 Million | 12.51 Million |
| Debt repayment | -97.06 Million | -33.87 Thousand | -31.94 Million | -83.38 Million | -336.53 Million | -215.82 Million |
| Dividends payments | -63.17 Million | -76.08 Million | -72.53 Million | -25.86 Million | -14.27 Million | -44.25 Million |
| Common Stock Repurchased | -30.99 Million | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -104.38 Million | -1.77 Million | 1.01 Billion | 16.33 Million | 1.03 Billion | 272.6 Million |
| Accounts receivables | -125.21 Million | -75.05 Million | -75.33 Million | -93.81 Million | -65.64 Million | -50.85 Million |
| Accounts payables | 6.57 Million | 82.14 Million | 8.93 Million | 117.17 Million | 54.99 Million | -5.54 Million |
| Inventory | -59.3 Million | 3.55 Million | 22.89 Million | -65.03 Million | 18.81 Million | -43.97 Million |
| Other working capital | -131.98 Million | 12.85 Million | 14.77 Million | 18.04 Million | -4.46 Million | -59.43 Million |
| Cash at beginning of period | 1.38 Billion | 708.73 Million | 207.99 Million | 388.47 Million | 71.67 Million | 111.32 Million |
| Cash at end of period | 521.93 Million | 1.38 Billion | 708.73 Million | 207.99 Million | 388.47 Million | 71.67 Million |
| Capital Expenditure | -451.7 Million | -293.69 Million | -524.68 Million | -223.14 Million | -166.89 Million | -239.32 Million |
| Effect of forex changes on cash | -4.58 Million | 29.85 Million | -11.27 Million | -12.16 Million | 2.18 Million | 3.05 Million |
| Net cash flow / Change in cash | -867.51 Million | 680.72 Million | 500.74 Million | -180.47 Million | 316.79 Million | -39.64 Million |
| Free Cash Flow | -65.62 Million | 151.16 Million | -183.3 Million | 96.42 Million | 64.7 Million | -55.86 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 85.32 Million | 91.44 Million | 63.02 Million | 95.89 Million | 240.28 Million | 83.96 Million |
| Depreciation & Amortization | - | 69.73 Million | 69.73 Million | 65.34 Million | 256.95 Million | -104.56 Million |
| Deferred income taxes | - | - | - | - | -13.33 Million | - |
| Stock-based compensation | - | 6.64 Million | - | 1.73 Million | 1.73 Million | - |
| Change in working capital | - | -138.94 Million | - | -202.75 Million | -191.28 Million | 171.65 Million |
| Other non-cash items | 80.79 Million | 168.63 Million | -135.33 Million | 53.22 Million | 80.12 Million | 13.15 Million |
| Investing Cash Flow | -103.48 Million | 52.38 Million | -77.14 Million | -10.98 Million | -1.15 Billion | -164.81 Million |
| Investments in PPE | -94.69 Million | -71.04 Million | -105.47 Million | -129.06 Million | -451.7 Million | -136.7 Million |
| Acquisitions | -121.96 Thousand | 152.96 Thousand | 0.73 | 74.72 Million | -707.54 Million | 289.3 Thousand |
| Investment purchases | - | -115.11 Million | -54.88 Million | -382.56 Million | -682.56 Million | -100 Million |
| Sales/Maturities of investments | 8.76 Million | 239.91 Million | 70.72 Million | 198.71 Million | 581.61 Million | 212.06 Million |
| Other Investing Activities | -17.56 Million | -1.52 Million | 12.48 Million | 227.2 Million | 102.33 Million | -140.45 Million |
| Financing Cash Flow | 6.28 Million | -160.45 Million | 28.35 Million | -21.32 Million | -91.14 Million | 26.17 Million |
| Debt repayment | -20.21 Million | -40.49 Million | -42.17 Million | -53.95 Million | -97.06 Million | -50.15 Million |
| Dividends payments | -10.48 Million | -210.36 Million | -1.75 Million | -63.17 Million | -63.17 Million | -47.44 Thousand |
| Common Stock Repurchased | 8.91 Million | -8.91 Million | - | -30.99 Million | -30.99 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3.43 Million | -180.72 Million | -12.06 Million | -62.57 Million | -104.38 Million | 76.37 Million |
| Accounts receivables | - | -54.82 Million | - | -125.21 Million | -125.21 Million | 65.16 Million |
| Accounts payables | - | - | - | - | 6.57 Million | - |
| Inventory | - | -66.45 Million | - | -59.3 Million | -59.3 Million | 206.36 Million |
| Other working capital | - | -17.66 Million | - | -18.23 Million | -131.98 Million | -99.88 Million |
| Cash at beginning of period | 483.56 Million | 413.7 Million | 521.93 Million | 474.79 Million | 1.38 Billion | 459.72 Million |
| Cash at end of period | 554.14 Million | 485.15 Million | 403.85 Million | 521.93 Million | 521.93 Million | 474.79 Million |
| Capital Expenditure | -94.69 Million | -71.04 Million | -105.47 Million | -129.06 Million | -451.7 Million | -136.7 Million |
| Effect of forex changes on cash | -577.5 Thousand | -2.55 Million | 3 Million | -14.06 Million | -4.58 Million | 619.32 Thousand |
| Net cash flow / Change in cash | 70.57 Million | 71.44 Million | -118.08 Million | 47.14 Million | -867.51 Million | 15.06 Million |
| Free Cash Flow | 71.42 Million | 119.3 Million | -177.77 Million | -35.55 Million | -65.62 Million | 27.5 Million |
NPR
PEY
CZNL
300815
000518
PVH